Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Bristol-Myers Squibb Company (BMY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 88,167,088
  • Shares Outstanding, K 1,634,540
  • Annual Sales, $ 20,776 M
  • Annual Income, $ 1,007 M
  • 36-Month Beta 0.95
  • Price/Sales 4.34
  • Price/Cash Flow 15.57
  • Price/Book 6.94

Price Performance

See More
Period Period Low Period High Performance
1-Month
49.97 +10.35%
on 06/04/18
55.33 -0.34%
on 06/22/18
+2.80 (+5.35%)
since 05/22/18
3-Month
49.96 +10.37%
on 05/08/18
64.05 -13.91%
on 03/23/18
-8.81 (-13.78%)
since 03/22/18
52-Week
49.96 +10.37%
on 05/08/18
70.05 -21.28%
on 02/16/18
-2.19 (-3.82%)
since 06/22/17

Most Recent Stories

More News
Bristol-Myers' BLA for Opdivo Label Expansion Accepted by FDA

Bristol-Myers Squibb Company (BMY) announces that the FDA accepts its supplemental Biologics License Application (sBLA) for the label expansion of its blockbuster immuno-oncology drug Opdivo.

AGLE : 10.72 (+2.29%)
MRK : 61.47 (+0.47%)
RHHBY : 27.7700 (+2.51%)
BMY : 55.14 (+2.22%)
Watch for Bristol-Myer Sqb to Potentially Pullback After Gaining 2.18% Yesterday

Bristol-Myer Sqb (NYSE:BMY) traded in a range yesterday that spanned from a low of $54.24 to a high of $55.15. Yesterday, the shares gained 2.2%, which took the trading range above the 3-day high of...

BMY : 55.14 (+2.22%)
Pharma Stock Roundup: PTCT Unveils Promising Data, RHHBY to Acquire Rest of FMI

Roche (RHHBY) will buy the remaining stake in Foundation Medicine for $2.4 billion. PTC Therapeutics (PTCT) presents encouraging preliminary data from an early-stage study in spinal muscular atrophy.

PTCT : 36.01 (-0.83%)
FMI : 136.70 (+0.22%)
NVO : 46.84 (+0.95%)
RHHBY : 27.7700 (+2.51%)
PFE : 36.51 (+0.58%)
GSK : 40.89 (+0.20%)
BMY : 55.14 (+2.22%)
Bristol-Myer Sqb (BMY) Breaks Through Resistance at $54.39

Bristol-Myer Sqb (NYSE:BMY) has opened bullishly above the pivot of $53.94 today and has reached the first level of resistance at $54.39. Investors may be interested in a cross of the next upside pivot...

BMY : 55.14 (+2.22%)
U.S. Food and Drug Administration (FDA) Accepts Application for Opdivo Plus Low-Dose Yervoy for Treatment of First-Line Non-Small Cell Lung Cancer in Patients with Tumor Mutational Burden greater-than or equal to10 mut/Mb

--Submission based on positive results from Part 1 of the Phase 3 study CheckMate -227

BMY : 55.14 (+2.22%)
Initiating Free Research Reports on Bristol-Myers Squibb and Three Other Drug Makers Equities

Stock Research Monitor: ABBV, AZN, and LLY

AZN : 35.06 (-0.26%)
LLY : 85.92 (-0.17%)
ABBV : 93.49 (-2.16%)
BMY : 55.14 (+2.22%)
Dallas Cowboys Quarterback Dak Prescott, Modern Family Star Eric Stonestreet and Actress Tia Mowry Call on Americans to Rise Up Against Cancer Through Ready. Raise. Rise.

--New Pic Your Power Challenge Helps Raise Funds for Thirty-Five Participating Cancer Advocacy Groups

BMY : 55.14 (+2.22%)
Bristol-Myers Posts Data on Empliciti, China Approves Opdivo

Bristol-Myers (BMY) announces positive results on oncology drug Empliciti. The company's blockbuster drug, Opdivo, was also approved in China for lung cancer.

MRK : 61.47 (+0.47%)
ABBV : 93.49 (-2.16%)
RHHBY : 27.7700 (+2.51%)
BMY : 55.14 (+2.22%)
Bristol-Myer Sqb (BMY) Breaks Through Support at $54.17

Shares of Bristol-Myer Sqb (NYSE:BMY) opened today below their pivot of $54.49 and have already reached the first level of support at $54.17. Analysts will be watching for a cross of the next downside...

BMY : 55.14 (+2.22%)
Empliciti (elotuzumab) Plus Pomalidomide and Low-Dose Dexamethasone Reduces the Risk of Disease Progression by 46% Versus Pomalidomide/Dexamethasone Alone in Patients with Relapsed or Refractory Multiple Myeloma

--Data will be presented for the first time in late-breaking oral session during the 23rd Congress of the European Hematology Association

BMY : 55.14 (+2.22%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade BMY with:

Business Summary

Bristol-Myers Squibb is a differentiated company, led by their unique BioPharma strategy that leverages the reach and resources of a major pharma company paired with the entrepreneurial spirit and agility of a biotech firm. They work every day to deliver innovative medicines for patients with serious...

See More

Key Turning Points

2nd Resistance Point 55.99
1st Resistance Point 55.57
Last Price 55.14
1st Support Level 54.48
2nd Support Level 53.81

See More

52-Week High 70.05
Fibonacci 61.8% 62.38
Fibonacci 50% 60.01
Fibonacci 38.2% 57.63
Last Price 55.14
52-Week Low 49.96

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar